United States:
Ready Or Not, It's Time For Phase 2 HIPAA Audits
To print this article, all you need is to be registered or login on Mondaq.com.
Our colleagues,
Dianne Bourque,
Jordan Cohen, and
Kate Stewart, wrote an excellent post on our sister blog,
Health Law and Policy Matters, on the official launch of
Phase 2 of the HIPAA Audit Program. You can read it
here. The authors outline what Covered Entities and Business
Associates can expect during the audit process and how they can
prepare.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...